Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: AC Immune raises $43.5M

    AC Immune S.A. (Lausanne, Switzerland) said it raised about $43.5 million in series E funding. Spokesperson Eva Schier declined to name the investors. The company is developing therapeutics and diagnostics for diseases …

    Published on 5/9/2016
  • FINANCIAL NEWS: Financial tracks

    Merck Global Health Innovation Fund named Francesca Wuttke managing director. Wuttke was head of strategic market intelligence and business insights for licensing and M&A transactions at Almirall S.A. (Madrid:ALM).

    Published on 5/9/2016
  • FINANCIAL NEWS: ACT Genomics raises $12.5M series B

    Diagnostics developer ACT Genomics Co. Ltd. (Taipei City, Taiwan) raised $12.5 million in a series B round led by Hotung Group and CDIB Capital Management. Existing investors including the Eminent II fund of TaiAn …

    Published on 5/6/2016
  • FINANCIAL NEWS: Intellia prices IPO

    Gene editing company Intellia Therapeutics Inc. (NASDAQ:NTLA) raised $108 million on Thursday through the sale of 6 million shares at $18 in an IPO underwritten by Credit Suisse, Jefferies, Leerink and Wedbush PacGrow. …

    Published on 5/5/2016
  • FINANCIAL NEWS: Synergy raises $89.9M in direct offering

    Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) raised $89.8 million through the sale of 29.9 million shares to institutional investors at $3 in a registered direct offering.FDA is reviewing Synergy's plecanatide (SP-304), a…

    Published on 5/5/2016
  • FINANCIAL NEWS: ViewPoint raises $4M in series A

    ViewPoint Therapeutics Inc. (San Francisco, Calif.) raised $4 million in a series A round co-led by Mission Bay Capital and Lagunita BioSciences. Biotechnology Value Fund, the University of Michigan MINTS initiative, …

    Published on 5/5/2016
  • FINANCIAL NEWS: Financial tracks

    LSP Life Science Partners named Vincent Brichard venture partner. Brichard was SVP of biologicals at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK).LifeSci Advisors named Niki Dilger advisory managing director and head of …

    Published on 5/4/2016
  • FINANCIAL NEWS: Koch joins OrbiMed as venture partner

    OrbiMed named Kevin Koch a venture partner. He was SVP of drug discovery for chemical and molecular therapeutics at Biogen Inc. (NASDAQ:BIIB). Before that, Koch was president and CSO of cancer company Array BioPharma …

    Published on 5/4/2016
  • FINANCIAL NEWS: Relypsa sinks after debt financing

    Relypsa Inc. (NASDAQ:RLYP) sank $3.32 (19%) to $14 on Wednesday after it closed a $150 million debt offering underwritten by Athyrium Capital Management and Healthcare Royalty Partners. The debt matures on April 27, …

    Published on 5/4/2016
  • FINANCIAL NEWS: RNAi play Sirnaomics raises $10M

    Sirnaomics Inc. (Gaithersburg, Md.) raised $10 million in a series B round from Hong Kong-based venture firm Value Measured Investment Ltd. CMO Michael Molyneaux told BioCentury the round will allow Sirnaomics to …

    Published on 5/4/2016
  • FINANCIAL NEWS: Gene therapy play Orchard raises L21M

    Orchard Therapeutics (London, U.K.) raised L21 million ($30.7 million) in a series A round to develop ex vivo autologous hematopoietic stem cell gene therapies for primary immune deficiencies, metabolic diseases and …

    Published on 5/3/2016
  • FINANCIAL NEWS: Ideaya raises $46M series A

    Cancer company Ideaya Biosciences Inc. (South San Francisco, Calif.) raised $46 million in a series A round from 5AM Ventures, Canaan Partners, Celgene Corp. (NASDAQ:CELG), WuXi Healthcare Ventures, Novartis Institute …

    Published on 5/3/2016
  • FINANCIAL NEWS: MVM closes fourth fund at $233M

    MVM Life Science Partners closed its fourth fund, MVM IV, at $233 million. The firm said it will invest $15-$30 million per company in healthcare companies of all stages in the U.S. and Europe. MVM invests in …

    Published on 5/3/2016
  • FINANCIAL NEWS: Verdine joins WuXi venture arm

    WuXi Healthcare Ventures hired Gregory Verdine as a venture partner. Verdine, a chemistry professor at Harvard University, is the co-founder of numerous biotechs, including natural products company Warp Drive Bio LLC (…

    Published on 5/3/2016
  • FINANCIAL NEWS: 5AM incubator spinout Homology raises $43.5M

    Gene editing company Homology Medicines Inc. spun out of 5AM Ventures' incubator with a $43.5 million series A round led by 5AM and Arch Venture Partners. Temasek, Deerfield and Arch Overage Fund also participated. …

    Published on 5/2/2016
  • FINANCIAL NEWS: Ophthalmic play Graybug raises $44.5M

    Graybug Vision Inc. (Redwood City, Calif.) raised $44.5 million in a series B round led by new investor Deerfield. New investors OrbiMed Advisors and Clarus Ventures also participated, along with existing investor …

    Published on 5/2/2016
  • FINANCIAL NEWS: Former Kythera team raises $34M for Sienna

    Aesthetic dermatology play Sienna Biopharmaceuticals Inc. (Westlake Village, Calif.) raised $34 million in a series A round. The start-up's management team includes former executives from aesthetics company Kythera …

    Published on 4/29/2016
  • FINANCIAL NEWS: Theravance, Ignyta raise follow-ons

    Theravance Biopharma Inc. (NASDAQ:TBPH) and Ignyta Inc. (NASDAQ:RXDX) raised a combined $150 million in follow-ons. Theravance raised $100.1 million through the sale of 4.8 million shares at $21. The company proposed …

    Published on 4/29/2016
  • FINANCIAL NEWS: Gilead HCV sales short of expectations in 1Q16

    Gilead Sciences Inc. (NASDAQ:GILD) slipped $5.35 to $91.65 in early after-hours trading Thursday after it reported 1Q16 earnings that missed analysts' estimates, in part due to lower than expected revenue from HCV drug …

    Published on 4/28/2016
  • FINANCIAL NEWS: Samsung BioLogics sets sights on Korean IPO

    Contract manufacturer Samsung BioLogics (Seoul, South Korea) is planning to list shares in South Korea this year. The company plans to select lead managers next month before deciding on the number of shares and timing.…

    Published on 4/28/2016
  • FINANCIAL NEWS: UBS, MPM close $471M cancer fund

    UBS Group AG (NYSE:UBS) raised $471 million for the UBS Oncology Impact Fund, which will invest in early stage cancer treatments. MPM Capital is collaborating with UBS on the fund. UBS said it will invest a portion of …

    Published on 4/27/2016
  • FINANCIAL NEWS: Vertex sales jump but Orkambi misses estimates

    Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) reported 1Q16 revenues of $398.1 million, up from $138.5 million in 1Q15 but missing analysts' estimates of $439.4 million. The shortfall was attributable to cystic fibrosis …

    Published on 4/27/2016
  • FINANCIAL NEWS: Allied Minds creates funding vehicle for BMS JV

    The newly formed ABLS Capital subsidiary of Allied Minds plc (LSE:ALM) has secured commitments of up to $80 million to fund programs in Allied Minds' joint venture with Bristol-Myers Squibb Co. (NYSE:BMY). The funds …

    Published on 4/26/2016
  • FINANCIAL NEWS: Cancer play FLX raises $50M in series B

    FLX Bio Inc. (South San Francisco, Calif.) raised $50 million in a series B round with The Column Group, Topspin Partners, Kleiner Perkins Caufield & Byers and Celgene Corp. (NASDAQ:CELG). FLX's lead product, FLX925, is…

    Published on 4/26/2016
  • FINANCIAL NEWS: Weill's $185M gift creates UCSF neuroscience institute

    The University of California San Francisco said the Weill Family Foundation and Joan and Sanford Weill donated $185 million to establish the UCSF Weill Institute for Neurosciences. The university said the donation is …

    Published on 4/26/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993